Warning letters for direct-to-consumer advertising: a five-year retrospective analysis
By Soundarya Rai, Garima Bansal, Akash Chimegave, Sandeep Maharaj and Manthan D Janodia2023-09-01T00:05:00
Background: Direct-to-consumer pharmaceutical advertising (DTCPA) is a ‘grey area’ that the Food and Drugs Administration (FDA) in the United States (US) regulates through the Centre for Drug Evaluation and Research (CDER). One of the purposes of DTCPA is to educate and empower patients via popular media such as television, radio, ...